- Home
- MIAX vs ZLAB Comparison
MIAX vs ZLAB Comparison
Compare MIAX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIAX
- ZLAB
- Stock Information
- Founded
- MIAX 2007
- ZLAB 2013
- Country
- MIAX United States
- ZLAB China
- Employees
- MIAX N/A
- ZLAB N/A
- Industry
- MIAX Investment Bankers/Brokers/Service
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- MIAX Finance
- ZLAB Health Care
- Exchange
- MIAX Nasdaq
- ZLAB Nasdaq
- Market Cap
- MIAX 3.1B
- ZLAB 3.4B
- IPO Year
- MIAX 2025
- ZLAB 2017
- Fundamental
- Price
- MIAX $38.24
- ZLAB $32.58
- Analyst Decision
- MIAX Buy
- ZLAB Buy
- Analyst Count
- MIAX 6
- ZLAB 6
- Target Price
- MIAX $40.00
- ZLAB $57.22
- AVG Volume (30 Days)
- MIAX 794.4K
- ZLAB 819.9K
- Earning Date
- MIAX 01-01-0001
- ZLAB 11-11-2025
- Dividend Yield
- MIAX N/A
- ZLAB N/A
- EPS Growth
- MIAX N/A
- ZLAB N/A
- EPS
- MIAX 0.02
- ZLAB N/A
- Revenue
- MIAX $1,255,413,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- MIAX N/A
- ZLAB $42.62
- Revenue Next Year
- MIAX N/A
- ZLAB $55.12
- P/E Ratio
- MIAX $1,854.46
- ZLAB N/A
- Revenue Growth
- MIAX 19.63
- ZLAB 32.56
- 52 Week Low
- MIAX $28.63
- ZLAB $20.17
- 52 Week High
- MIAX $39.56
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- MIAX N/A
- ZLAB 48.51
- Support Level
- MIAX N/A
- ZLAB $31.68
- Resistance Level
- MIAX N/A
- ZLAB $33.06
- Average True Range (ATR)
- MIAX 0.00
- ZLAB 1.34
- MACD
- MIAX 0.00
- ZLAB 0.21
- Stochastic Oscillator
- MIAX 0.00
- ZLAB 80.97
About MIAX Miami International Holdings Inc. Common Stock
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.